ERS Highlights

flipper_slider

Editor's Choice

Gerard Criner shares his highlights of this year’s ERS – most significant recent developments, unmet needs and challenges, as well as hopes and expectations for future in pulmonary medicine. Speaker disclosures:...

ERS Highlights Videos

Gerard Criner shares his highlights of this year’s ERS – most significant recent developments, unmet needs and challenges, as well as hopes and expectations for future in pulmonary medicine. Speaker disclosures: grants from US NIH and the Department of Defense, consulting from AstraZeneca,...
Ian Adcock talks to us about recent developments, unmet needs and challenges, as well as hopes and expectations for future in the treatment of asthma/COPD. Filmed at the European Respiratory Society (ERS) International Congress, Milan, September 2017.
Fabio Midulla discusses paediatric bronchiolitis and respiratory syncytial virus (RSV). Filmed at the European Respiratory Society (ERS) International Congress, Milan, September 2017.
Peter Barnes discusses new treatments for COPD. Filmed at the European Respiratory Society (ERS) International Congress, Milan, September 2017.
Refika Ersu discusses sleep problems in children with chronic lung disease, the topic of her recent editorial, which can be read here. Filmed at the European Respiratory Society (ERS) International Congress, Milan, September 2017.
Felix Herth discusses interventional pneumology and endoscopic lung volume reduction (ELVR). Filmed at the European Respiratory Society (ERS) International Congress, Milan, September 2017.
Mario Cazzola talks to us about recent developments, unmet needs and challenges, as well as hopes and expectations for future in the treatment of asthma/COPD. Speaker disclosures: serves as a consultant to Novartis, Boehringer Ingelheim, Chiesi, Zambon, ABI Pharmaceutical and Menarini. Filmed...
Antonio Spanevello discusses methods to assess airway inflammation in asthma. Speaker disclosures: serves as a consultant to GSK, Novartis, Lusofarmaco, AstraZeneca, Boehringer Ingelheim, Malesci, Guidotti, Chiesi and Menarini. Filmed at the European Respiratory Society (ERS) International...
Dave Singh discusses the use of MABAs in the treatment of COPD and the key findings of the TRILOGY and TRINITY studies. FILMED AT THE EUROPEAN RESPIRATORY SOCIETY (ERS) INTERNATIONAL CONGRESS, SEPTEMBER 2016 The use of MABAs is a novel approach to the treatment of COPD. What are their major...
Mario Cazzola discusses pharmacotherapy of COPD. Disclosures: Mario Cazzola has participated as a speaker, and adviser in scientific meetings and courses under sponsorship of Almirall, AstraZeneca, Biofutura, Boehringer Ingelheim, Chiesi Farmaceutici, GlaxoSmithKline, Menarini Group, Lallemand,...
Fabio Midulla discusses the prevalence and clinical consequences of infections in hospitalised children with respiratory symptoms. FILMED AT THE EUROPEAN RESPIRATORY SOCIETY (ERS) INTERNATIONAL CONGRESS, SEPTEMBER 2016 Can you tell us a little about the prevalence and clinical consequences of...
Tobias Welte gives an overview of the main challenges in the diagnosis of nontuberculous mycobacteria (NTM). Disclosures: Tobias Welte receives honarium for lectures and participation in an advisory board from Insmed. FILMED AT THE EUROPEAN RESPIRATORY SOCIETY (ERS) INTERNATIONAL CONGRESS,...
Ian Adcock gives an overview of targeted therapies in COPD. Disclosures: Ian Adcock was a co-leader of the IMI U-BIOPRED project and in the MRC-ABPI COPDMAP project FILMED AT THE EUROPEAN RESPIRATORY SOCIETY (ERS) INTERNATIONAL CONGRESS, SEPTEMBER 2016 Why have so many targeted therapies...
Antonio Spanevello discusses the role of eosinophilic inflammation in COPD. FILMED AT THE EUROPEAN RESPIRATORY SOCIETY (ERS) INTERNATIONAL CONGRESS, SEPTEMBER 2016 What is understood about the role of eosinophilic inflammation in airway remodelling? 00:11 – In the recent studies, there are a...
Refika Ersu discusses the CHAT trial and remaining unmet needs in the diagnosis and treatment of OSAS. FILMED AT THE EUROPEAN RESPIRATORY SOCIETY (ERS) INTERNATIONAL CONGRESS, SEPTEMBER 2016 The CHAT trial confirmed the benefit of early adenotonsillectomy in children with OSAS. Could you tell...